Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing

Abstract

There is little information on the progression of peripheral arterial disease (PAD) over time. A series of 508 patients with a prior examination for PAD were contacted and brought in for follow-up to evaluate the natural history of PAD. A total of 85 patients were excluded because they had interventions in both limbs prior to their return visit. Progression was assessed in the remaining 423 patients for a total of 755 limbs, both quantitatively and qualitatively using six categories of PAD severity. There was a modest overall categorical progression of disease: 228 limbs (30.2%) displayed categorical progression, while 172 limbs (22.8%) improved over a 4.6-year average follow-up. Through analysis of quantitative change, it was determined that more quantitative progression occurred than was evident from categorical progression. Two of the three non-invasive tests employed, the ankle/brachial index (ABI) and posterior tibial peak forward flow velocity (peak PT), showed statistically significant progression during follow-up: mean ABI change =-0.019, 95% confidence interval (CI) =-0.031 to -0.007; mean peak PT change =-2.32 cm/s, 95% CI =-3.20 to -1.44. The toe/brachial index (TBI) also suggested progression: mean change =-0.013, but the 95% CI included no change. Standard scores (sum of the Z-scores for ABI, peak PT and TBI) were calculated. The standard score progressed approximately 0.34 units (standard deviations), p-value,0.001, over 4.6 years; or about 0.07 standard deviations per year. There were independent and statistically significant (p, 0.05) associations between the rate of PAD progression (standard score change) and age, diabetes, classic (`Rose') intermittent claudication, moderate to severe PAD in the same limb, moderate to severe PAD in the contralateral limb and future therapeutic intervention. There were independent and suggestive associations (0.05, p-value, 0.15) between PAD progression and pain at rest, mild PAD in the same limb, and mild PAD in the contralateral limb. PAD progression was not associated with gender, atypical claudication, or amputation status.

Thus, in this cohort of PAD patients, PAD on average progressed significantly over 4.6 years. This progression was independently related to age, diabetes and several markers of disease severity.

Keywords

ankle/brachial index diabetes mellitus disease progression intermittent claudication non-invasive diagnosis peripheral vascular disease

References

Dormandy J , Mahir M , Ascady G et al. Fate of the patient with chronic leg ischemia. J Cardiovasc Surg 1989; 30: 50-57.

Balsano F , Violi F , and the ADEP group . Effect of picotamide on the clinical progression of peripheral vascular disease: a double-blind placebo-controlled study. Circulation 1993; 87: 1563-1569.

Coni NK. Peripheral vascular disease - the geriatrician’s tale. Postgrad Med J 1985; 61: 1049-1053.

De Backer JG , Kornitzer M , Sobolski J , Denolin H. Intermittent claudication - epidemiology and natural history. Acta Cardiol 1979; 3: 115-124.

Dormandy JA , Murray GD. The fate of the claudicant - a prospective study of 1969 claudicants. J Vasc Surg 1991; 5: 131-133.

Fowkes FGR. Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 1988; 2: 283-291.

Jelnes R , Gaardsting O , Hougaard Jensen K , Baekgaard N , Tonnesen KH , Schroeder T. Fate in intermittent claudication: outcome and risk factors. Br Med J 1986; 293: 1137-1140.

Kreines K , Johnson E , Albrink M et al. The course of peripheral vascular disease in non-insulin-dependent diabetes. Diabetes Care 1985; 8: 235-243.

Prevention of Atherosclerotic Complications with Ketanserin (PACK) Trial Group . Prevention of atherosclerotic complications: controlled trial of ketanserin. Br Med J 1989; 289: 424-430.

10.

Peabody CN , Kannel WB , McNamara PM. Intermittent claudication: surgical significance. Arch Surg 1974; 109: 693-696.

11.

Radack K , Wyderski RJ. Conservative management of intermittent claudication. Ann Intern Med 1990; 113: 135-146.

12.

Smith GD , Shipley MJ , Rose G. Intermittent claudication, heart disease, and mortality; The Whitehall Study. Circulation 1990; 82: 1925-1931.

13.

Duffield RGM , Lewis B , Miller NE , Jamieson CW , Brunt JNH , Col-chester ACF. Treatment of hyperlipidemia retards progression of symptomatic femoral atherosclerosis: a randomized controlled trial. Lancet 1983; ii: 639-642.

14.

Hess H , Mietaschk A , Deichsel G. Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease: a prospective double-blind arteriographically controlled trial. Lancet 1985; i: 415-419.

15.

Jonason T , Bergstrom R. Cessation of smoking in patients with intermittent claudication: effects of the risks of peripheral vascular disease complications, myocardial infarction, and mortality. Acta Med Scand 1987; 221: 253-260.

16.

Ogren M , Hedblad B , Isacsson SO , et al. Plethysmographic pulse wave amplitude and future leg arteriosclerosis. Atherosclerosis 1995; 113: 55-62.

17.

Walsh DB , Gilbertson JJ , Zwolack RM et al. The natural history of superficial femoral artery stenoses. J Vasc Surg 1991; 14: 299-304.

18.

Osmundson PJ , O’Fallon WM , Zimmerman BR , Kazmier FJ , Lang-worthy AL , Palumbo PJ. Course of peripheral occlusive arterial disease in diabetes: vascular laboratory assessment. Diabetes Care 1990; 13: 143-152.

19.

Fowkes FG , Lowe GD , Housley E et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993; 342: 84-86.

20.

Thulesius O. Principles of pressure measurement. In: Bernstein E ed. Non-invasive diagnostic techniques in vascular disease, third edition. St Louis: CV Mosby, 1985: 77-82.

21.

Fronek A. Arterial system (evaluation of the lower and upper extremities). In: Fronek A ed. Noninvasive diagnostics in vascular disease. New York: McGraw-Hill, 1989: 88-95.

22.

Fronek A , Coel M , Bernstein EF. Quantitative ultrasonographic studies of lower extremity flow velocities in health and disease. Circulation 1976; 53: 957-960.

23.

Fowkes FGR , Housley E , Macintyre CCA , Prescott RJ , Ruckley CV. Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease. J Epidemiol Community Health 1988; 42: 128-133.

24.

Osmundson PJ , O’Fallon WM , Clements IP , Kazmier FJ , Zimmerman R , Palumbo PJ. Reproducibility of noninvasive tests of peripheral occlusive arterial disease. J Vasc Surg 1985; 2: 678-683.

25.

Johnston KW , Hosang MY , Andrews DF. Reproducibility of noninvasive vascular laboratory measurements of the peripheral circulation. J Vasc Surg 1987; 6: 147-151.

26.

Lezack JD , Carter SA. Systolic pressures in the extremities of man with special reference to the toes. Can J Physiol Pharmacol 1970; 48: 469-474.

27.

Sawka AM , Carter SA. Effect of temperature on digital systolic pressures in lower limb in arterial disease. Circulation 1992; 85: 1097-1101.

28.

Feigelson HS , Criqui MH , Fronek A , Langer RD , Molgaard CA. Diagnosing peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am J Epidemiol 1994; 140: 526-534.

29.

Criqui MH , Fronek A , Klauber MR , Barrett-Connor E , Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from a noninvasive testing in a defined population. Circulation 1985; 71: 516-522.

30.

Criqui MH , Denenberg JO , Bird CE , Fronek A , Klauber MR , Langer RD. The correlation between symptoms and noninvasive test results in patients referred for peripheral arterial disease testing. Vasc Med 1996; 1: 65-71.

31.

Criqui MH , Fronek A , Barrett-Connor E , Klauber MR , Gabriel S , Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71:510-515.

32.

Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962; 27: 645-658.

33.

Leng GC , Fowkes FGR. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose questionnaire for use in epidemiologic surveys. J Clin Epidemiol 1992; 45: 1101-1109.

34.

Criqui MH , Langer RD , Fronek A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-386.

35.

Duprez D. Natural history and evolution of peripheral obstructive arterial disease. Int Angiol 1992; 11: 165-168.

36.

Palumbo PJ , O’Fallon WM , Osmundson PJ , Zimmerman BR , Lang-worthy AL , Kazmier FJ.

Progression of peripheral occlusive arterial disease in diabetes mellitus: what factors are predictive?

Arch Intern Med 1991; 151: 717-721.

37.

Christensen JH , Freundlich M , Jacobsen BA , Falstie-Jensen N. Clinical relevance of pedal pulse palpation in patients suspected of peripheral arterial insufficiency. J Intern Med 1989; 226: 95-99.